Showing 1 - 20 results of 34 for search 'Emmanuel Raffoux', query time: 0.06s
Refine Results
-
1
-
2
-
3
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis by Alexandre Alanio, Blandine Denis, Samia Hamane, Emmanuel Raffoux, Régis Peffault de Latour, Jean Menotti, Sandy Amorim, Sophie Touratier, Anne Bergeron, Stéphane Bretagne
Published 2016-01-01
Article -
4
Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia by Alexis Talbot, Régis Peffault de Latour, Emmanuel Raffoux, Nimrod Buchbinder, Stéphane Vigouroux, Noel Milpied, Thierry Leblanc, Jean Soulier, Mauricette Michallet, Gérard Socié
Published 2014-10-01
Article -
5
Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival. by Emmanuel Canet, Lara Zafrani, Jerome Lambert, Catherine Thieblemont, Lionel Galicier, David Schnell, Emmanuel Raffoux, Etienne Lengline, Sylvie Chevret, Michael Darmon, Elie Azoulay
Published 2013-01-01
Article -
6
Impact of post-remission therapy in patients aged 65–70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclu... by Raphael Itzykson, Claude Gardin, Cécile Pautas, Xavier Thomas, Pascal Turlure, Emmanuel Raffoux, Christine Terré, Pierre Fenaux, Sylvie Castaigne, Hervé Dombret, Nicolas Boissel
Published 2011-06-01
Article -
7
Cartridge-based automated BCR-ABL1 mRNA quantification: solving the issues of standardization, at what cost? by Jean-Michel Cayuela, Elizabeth Macintyre, Meryl Darlington, Raouf Ben Abdelali, Xavier Fund, Patrick Villarese, Michel Tulliez, Emmanuel Raffoux, François Sigaux, Delphine Réa, Valerie Seror
Published 2011-05-01
Article -
8
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complications. by Sofiane Fodil, Sylvie Chevret, Camille Rouzaud, Sandrine Valade, Florence Rabian, Eric Mariotte, Emmanuel Raffoux, Raphael Itzykson, Nicolas Boissel, Marie Sébert, Lionel Adès, Lara Zafrani, Elie Azoulay, Etienne Lengliné
Published 2022-01-01
Article -
9
NPM1 mutation is not associated with prolonged complete remission in acute myeloid leukemia patients treated with hypomethylating agents by Pedro Henrique Prata, Cécile Bally, Thomas Prebet, Christian Recher, Geoffroy Venton, Xavier Thomas, Emmanuel Raffoux, Arnaud Pigneux, Thomas Cluzeau, Judith Desoutter, Julie Gay, Claude Preudhomme, Pierre Fenaux, Lionel Adès
Published 2018-10-01
Article -
10
New Short Tandem Repeat-Based Molecular Typing Method for Pneumocystis jirovecii Reveals Intrahospital Transmission between Patients from Different Wards. by Maud Gits-Muselli, Marie-Noelle Peraldi, Nathalie de Castro, Véronique Delcey, Jean Menotti, Nicolas Guigue, Samia Hamane, Emmanuel Raffoux, Anne Bergeron, Sandrine Valade, Jean-Michel Molina, Stéphane Bretagne, Alexandre Alanio
Published 2015-01-01
Article -
11
Favorable pharmacokinetic and pharmacodynamic properties of gilteritinib in cerebrospinal fluid: a potential effective treatment in relapsing meningeal acute myeloid leukemia <i>FL... by Nicolas Vignal, Loïs Kelly, Etienne Lengline, Aurélie Cabannes-Hamy, Justine Siavellis, David Ghez, Hélène Sauvageon, Thorsten Braun, Evelyne Jacqz-Aigrain, Milena Kohn, Philippe Rousselot, Alexandre Puissant, Emmanuel Raffoux, Samia Mourah, Lauriane Goldwirt
Published 2023-02-01
Article -
12
Reducing mortality in newly diagnosed standard-risk acute promyelocytic leukemia in elderly patients treated with arsenic trioxide requires major reduction of chemotherapy: a repor... by Ramy Rahmé, Lionel Ades, Xavier Thomas, Agnès Guerci-Bresler, Arnaud Pigneux, Norbert Vey, Emmanuel Raffoux, Sylvie Castaigne, Olivier Spertini, Sebastian Wittnebel, Jean Pierre Marolleau, Gandhi Damaj, Dominique Bordessoule, Julie Lejeune, Sylvie Chevret, Pierre Fenaux
Published 2018-11-01
Article -
13
Panobinostat monotherapy and combination therapy in patients with acute myeloid leukemia: results from two clinical trials by Richard F. Schlenk, Jürgen Krauter, Emmanuel Raffoux, Karl-Anton Kreuzer, Markus Schaich, Lucien Noens, Thomas Pabst, Madhuri Vusirikala, Didier Bouscary, Andrew Spencer, Anna Candoni, Jorge Sierra Gil, Noah Berkowitz, Hans-Jochen Weber, Oliver Ottmann
Published 2018-01-01
Article -
14
Mesenchymal stromal cells confer chemoresistance to myeloid leukemia blasts through Side Population functionality and ABC transporter activation by Laetitia Boutin, Pierre Arnautou, Aurélie Trignol, Amandine Ségot, Thomas Farge, Christophe Desterke, Sabrina Soave, Denis Clay, Emmanuel Raffoux, Jean-Emmanuel Sarry, Jean-Valère Malfuson, Jean-Jacques Lataillade, Marie-Caroline Le Bousse-Kerdilès, Adrienne Anginot
Published 2020-04-01
Article -
15
Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study by Patrice Chevallier, Francoise Huguet, Emmanuel Raffoux, Anne Etienne, Thibaut Leguay, Francoise Isnard, Nelly Robillard, Thierry Guillaume, Jacques Delaunay, Aude Charbonnier, Arnaud Pigneux, Pierre Peterlin, Marie C. Bené, William A. Wegener, David M. Goldenberg, Hervé Dombret
Published 2015-04-01
Article -
16
Impact of additional genetic alterations on the outcome of patients with NPM1-mutated cytogenetically normal acute myeloid leukemia by Pierre Peterlin, Aline Renneville, Raouf Ben Abdelali, Olivier Nibourel, Xavier Thomas, Cécile Pautas, Stéphane de Botton, Emmanuel Raffoux, Jean-Michel Cayuela, Nicolas Boissel, Christine Terré, Karine Celli-Lebras, Sylvie Castaigne, Claude Preudhomme, Claude Gardin, Hervé Dombret
Published 2015-05-01
Article -
17
Lenalidomide combined with intensive chemotherapy in acute myeloid leukemia and higher-risk myelodysplastic syndrome with 5q deletion. Results of a phase II study by the Groupe Fra... by Lionel Ades, Thomas Prebet, Aspasia Stamatoullas, Christian Recher, Romain Guieze, Emmanuel Raffoux, Krimo Bouabdallah, Mathilde Hunault, Eric Wattel, Laure Stalnikiewicz, Andrea Toma, Hervé Dombret, Norbert Vey, Marie Sebert, Claude Gardin, Cendrine Chaffaut, Sylvie Chevret, Pierre Fenaux
Published 2017-04-01
Article -
18
Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial by Juliette Lambert, Cécile Pautas, Christine Terré, Emmanuel Raffoux, Pascal Turlure, Denis Caillot, Ollivier Legrand, Xavier Thomas, Claude Gardin, Karïn Gogat-Marchant, Stephen D. Rubin, Rebecca J. Benner, Pierre Bousset, Claude Preudhomme, Sylvie Chevret, Herve Dombret, Sylvie Castaigne
Published 2019-01-01
Article -
19
Biological Effects of BET Inhibition by OTX015 (MK-8628) and JQ1 in NPM1-Mutated (NPM1c) Acute Myeloid Leukemia (AML) by Hanane Djamai, Jeannig Berrou, Mélanie Dupont, Marie-Magdelaine Coudé, Marc Delord, Emmanuelle Clappier, Alice Marceau-Renaut, Anna Kaci, Emmanuel Raffoux, Raphaël Itzykson, Caroline Berthier, Hsin-Chieh Wu, Rita Hleihel, Ali Bazarbachi, Hugues de Thé, André Baruchel, Claude Gardin, Hervé Dombret, Thorsten Braun
Published 2021-11-01
Article -
20
Adverse prognostic significance of CD20 expression in adults with Philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia by Sébastien Maury, Françoise Huguet, Thibaut Leguay, Francis Lacombe, Marc Maynadié, Sandrine Girard, Adrienne de Labarthe, Emilienne Kuhlein, Emmanuel Raffoux, Xavier Thomas, Patrice Chevallier, Agnès Buzyn, André Delannoy, Yves Chalandon, Jean-Paul Vernant, Philippe Rousselot, Elizabeth Macintyre, Norbert Ifrah, Hervé Dombret, Marie-Christine Béné
Published 2010-02-01
Article